A detailed history of Pfm Health Sciences, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Pfm Health Sciences, LP holds 298,643 shares of LLY stock, worth $238 Million. This represents 15.52% of its overall portfolio holdings.

Number of Shares
298,643
Previous 298,643 -0.0%
Holding current value
$238 Million
Previous $270 Million 2.15%
% of portfolio
15.52%
Previous 13.89%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $51 Million - $63.3 Million
-226,812 Reduced 43.16%
298,643 $82.5 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $28.7 Million - $37.2 Million
174,810 Added 49.85%
525,455 $98.2 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $45.7 Million - $60.5 Million
350,645 New
350,645 $59.2 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.